Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study

BACKGROUND: Antimicrobial consumption in veterinary medicine is of great importance. Increased awareness by the public and media has led to demands for decreased use of antimicrobials in pigs. This study aimed to identify risk factors for regular oral antimicrobial consumption in Swiss fattening pig...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Corinne, Schüpbach-Regula, Gertraud, Hirsiger, Patricia, Malik, Julia, Scheer, Patricia, Sidler, Xaver, Spring, Peter, Peter-Egli, Judith, Harisberger, Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382424/
https://www.ncbi.nlm.nih.gov/pubmed/28405431
http://dx.doi.org/10.1186/s40813-016-0024-3
_version_ 1782520097291632640
author Arnold, Corinne
Schüpbach-Regula, Gertraud
Hirsiger, Patricia
Malik, Julia
Scheer, Patricia
Sidler, Xaver
Spring, Peter
Peter-Egli, Judith
Harisberger, Myriam
author_facet Arnold, Corinne
Schüpbach-Regula, Gertraud
Hirsiger, Patricia
Malik, Julia
Scheer, Patricia
Sidler, Xaver
Spring, Peter
Peter-Egli, Judith
Harisberger, Myriam
author_sort Arnold, Corinne
collection PubMed
description BACKGROUND: Antimicrobial consumption in veterinary medicine is of great importance. Increased awareness by the public and media has led to demands for decreased use of antimicrobials in pigs. This study aimed to identify risk factors for regular oral antimicrobial consumption in Swiss fattening pig farms, and to quantify the amount of antimicrobial active substances administered orally to pigs at the farm level. RESULTS: A case–control study was performed on 99 fattening farms between May 2014 and January 2015. Seventy-two case farms (with oral group treatment of antimicrobials in at least 50 % of pigs) and 27 control farms (with no regular oral group treatment) were visited once during the study. Data about potential risk factors and antimicrobial consumption were collected by questionnaire. Antimicrobial consumption was recorded and treatment incidence (TI) was calculated for all farms over a one year period. Sulphonamides and tetracyclines were the antimicrobials consumed in the greatest quantity. The median TI for oral antimicrobial use in the case group was 224.7. In the control group, the median TI was 0 for oral antimicrobial use, with values ranging from 0 to 140.1. In a multivariable regression model, seven risk factors associated with regular oral antimicrobial group treatment were identified: mixing pigs from different suppliers within the same pen, absence of a work protocol that ensures treating of healthy pigs before sick pigs, distance to next pig farm < 500 metres, external analysis of production parameters, no availability of dirty visitor boots, the farmer not working on other farms, and no application of homoeopathic agents. CONCLUSIONS: The results of this study point out the importance of increasing farmers’ awareness of good farming practices and biosecurity. Important recommendations for decreasing oral antimicrobial consumption identified by this study include avoiding mixing pigs from different suppliers in the same pen and strictly handling sick pigs after healthy ones. Improvements in these areas could enhance the overall health of pigs and thereby reduce the consumption of antimicrobials on pig farms.
format Online
Article
Text
id pubmed-5382424
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53824242017-04-12 Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study Arnold, Corinne Schüpbach-Regula, Gertraud Hirsiger, Patricia Malik, Julia Scheer, Patricia Sidler, Xaver Spring, Peter Peter-Egli, Judith Harisberger, Myriam Porcine Health Manag Research BACKGROUND: Antimicrobial consumption in veterinary medicine is of great importance. Increased awareness by the public and media has led to demands for decreased use of antimicrobials in pigs. This study aimed to identify risk factors for regular oral antimicrobial consumption in Swiss fattening pig farms, and to quantify the amount of antimicrobial active substances administered orally to pigs at the farm level. RESULTS: A case–control study was performed on 99 fattening farms between May 2014 and January 2015. Seventy-two case farms (with oral group treatment of antimicrobials in at least 50 % of pigs) and 27 control farms (with no regular oral group treatment) were visited once during the study. Data about potential risk factors and antimicrobial consumption were collected by questionnaire. Antimicrobial consumption was recorded and treatment incidence (TI) was calculated for all farms over a one year period. Sulphonamides and tetracyclines were the antimicrobials consumed in the greatest quantity. The median TI for oral antimicrobial use in the case group was 224.7. In the control group, the median TI was 0 for oral antimicrobial use, with values ranging from 0 to 140.1. In a multivariable regression model, seven risk factors associated with regular oral antimicrobial group treatment were identified: mixing pigs from different suppliers within the same pen, absence of a work protocol that ensures treating of healthy pigs before sick pigs, distance to next pig farm < 500 metres, external analysis of production parameters, no availability of dirty visitor boots, the farmer not working on other farms, and no application of homoeopathic agents. CONCLUSIONS: The results of this study point out the importance of increasing farmers’ awareness of good farming practices and biosecurity. Important recommendations for decreasing oral antimicrobial consumption identified by this study include avoiding mixing pigs from different suppliers in the same pen and strictly handling sick pigs after healthy ones. Improvements in these areas could enhance the overall health of pigs and thereby reduce the consumption of antimicrobials on pig farms. BioMed Central 2016-02-09 /pmc/articles/PMC5382424/ /pubmed/28405431 http://dx.doi.org/10.1186/s40813-016-0024-3 Text en © Arnold et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Arnold, Corinne
Schüpbach-Regula, Gertraud
Hirsiger, Patricia
Malik, Julia
Scheer, Patricia
Sidler, Xaver
Spring, Peter
Peter-Egli, Judith
Harisberger, Myriam
Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title_full Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title_fullStr Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title_full_unstemmed Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title_short Risk factors for oral antimicrobial consumption in Swiss fattening pig farms – a case–control study
title_sort risk factors for oral antimicrobial consumption in swiss fattening pig farms – a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382424/
https://www.ncbi.nlm.nih.gov/pubmed/28405431
http://dx.doi.org/10.1186/s40813-016-0024-3
work_keys_str_mv AT arnoldcorinne riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT schupbachregulagertraud riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT hirsigerpatricia riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT malikjulia riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT scheerpatricia riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT sidlerxaver riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT springpeter riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT petereglijudith riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy
AT harisbergermyriam riskfactorsfororalantimicrobialconsumptioninswissfatteningpigfarmsacasecontrolstudy